U.S. Ophthalmic Lasers Market was valued at USD 0.67 billion in 2025 and is expected to reach USD 1.14 billion by 2035, growing at a CAGR of 5.50%
Austin, April 06, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Ophthalmic Lasers Market size was estimated at USD 1.72 billion in 2025 and is expected to reach USD 2.94 billion by 2035, growing at a CAGR of 5.52% over 2026-2035.
Due to the increasing incidence of eye conditions such glaucoma, cataracts, diabetic retinopathy, and age-related macular degeneration (AMD), the global market for ophthalmic lasers is growing significantly.
The U.S. Ophthalmic Lasers Market size was valued at USD 0.67 billion in 2025 and is expected to reach USD 1.14 billion by 2035, growing at a CAGR of 5.50% over 2026-2035.
With a high density of ophthalmologists per capita, a well-established infrastructure of ambulatory surgery centers, and extensive Medicare and commercial insurance coverage for required ophthalmic laser procedures, the U.S. dominates the global market for ophthalmic lasers.
Request Instant Access to the Ophthalmic Lasers Market Forecast @ https://www.snsinsider.com/sample-request/8319
Rising Global Burden of Ocular Diseases and Aging Population to Propel Market Growth Globally
The primary structural growth driver for the ophthalmic lasers market continues to be the increasing prevalence of age-related ocular diseases, such as cataracts, glaucoma, AMD, and diabetic retinopathy. By 2050, there will be 2.1 billion people worldwide who are 60 years of age or older. Since people over 50 account for 80% of cases of vision impairment, this will directly increase the number of patients in need of laser-based ophthalmic intervention. Excimer and femtosecond laser systems continue to be used in outpatient refractive surgery facilities around the world as the prevalence of myopia among younger populations rises due to increased near-work activities and decreased outdoor exposure.
Ophthalmic Lasers Market Segmentation Analysis:
By Product
Femtosecond lasers held the largest revenue share of approximately 31.74% in 2025, driven by adoption in premium cataract surgery, LASIK enhancement, and corneal transplantation globally. Excimer lasers accounted for the second-largest share of ~26.92% in 2025, supported by stable refractive surgery volumes.
By Type
Photocoagulation lasers captured the largest revenue share of approximately 43.18% in 2025, driven by their established clinical role in treating diabetic retinopathy, retinal tears, and AMD across high-volume retinal specialty departments globally. The SLT segment is expected to achieve the highest CAGR of approximately 6.84% during 2026-2035, driven by expanding international guideline support positioning SLT as a first-line treatment for open-angle glaucoma.
By Application
Cataract removal led with approximately 32.67% share in 2025, driven by over 17 million annual surgeries and increasing femtosecond laser-assisted adoption in premium segments globally. Glaucoma is projected to grow at the highest CAGR of approximately 6.73% through 2035, due to expanding SLT first-line use, rising awareness of laser-based IOP control, and increasing prevalence in aging populations.
By End-User
Outpatient facilities accounted for the largest end-user share of approximately 62.44% in 2025 and are projected to grow at the highest CAGR of approximately 6.08% through 2035. The growth is driven by increasing shift of laser-based ophthalmic procedures from hospital inpatient settings to ambulatory surgical centers, refractive surgery clinics, and ophthalmology outpatient departments.
For an In-Depth Strategic Briefing with Our Research Team, Connect Now @ https://www.snsinsider.com/request-analyst/8319
Ophthalmic Lasers Market Regional Insights:
Due to the highest per-capita adoption of refractive laser correction treatments and premium femtosecond laser-assisted cataract surgery worldwide, North America had the largest revenue share of the ophthalmic lasers market in 2025, at over 40.82%.
Asia Pacific is the fastest-growing regional segment in the ophthalmic lasers market with a CAGR of 7.18%, driven by the world’s largest myopic population concentrated in China, India, Japan, and South Korea, rapidly expanding private ophthalmology infrastructure, and growing government investment in national eye health programs.
Major Players Analysis Listed in the Ophthalmic Lasers Market Report:
- Alcon Inc.
- Carl Zeiss Meditec AG
- Lumenis Ltd.
- Johnson & Johnson Vision Care, Inc.
- Bausch + Lomb Corporation
- IRIDEX Corporation
- Ellex Medical Lasers Limited
- Topcon Corporation
- Nidek Co., Ltd.
- SCHWIND eye-tech-solutions GmbH
- Ziemer Ophthalmic Systems AG
- Quantel Medical (Lumibird Group)
- A.R.C. Laser GmbH
- Coherent Corp.
- Wavelight GmbH (an Alcon Company)
- Lightmed Corporation
- BVI Medical
- Meridian AG
- Laserex Technologies Pty Ltd
- MPLUS X GmbH
Ophthalmic Lasers Market Recent Developments:
- In February 2025, Alcon launched an upgraded LenSx femtosecond laser system with enhanced AI-assisted pre-surgical planning and expanded arcuate incision customization capabilities, targeting the premium cataract surgery segment across North American and European ambulatory surgical center accounts.
- In June 2024, Carl Zeiss Meditec received FDA clearance for its VisuMax 800 femtosecond laser platform, enabling SMILE Pro refractive surgery in the United States for the first time, significantly expanding the company’s addressable market within the world’s largest premium refractive surgery economy.
Purchase Single User PDF of Ophthalmic Lasers Market Intelligence Report @ https://www.snsinsider.com/checkout/8319
Exclusive Sections of the Report (The USPs):
- OCULAR DISEASE BURDEN & PROCEDURE VOLUME METRICS – helps you understand prevalence trends of key eye disorders and their direct impact on ophthalmic laser procedure volumes across regions.
- TECHNOLOGY ADOPTION & DEVICE UTILIZATION ANALYSIS – helps you evaluate the adoption of femtosecond, excimer lasers, FLACS procedures, and AI-integrated laser platforms across clinical settings.
- CLINICAL DEMAND & REFRACTIVE SURGERY TRENDS – helps you identify correlations between myopia prevalence, refractive surgery demand, and unmet needs in preventable visual impairment treatment.
- REGULATORY APPROVAL & CLINICAL EVIDENCE INSIGHTS – helps you assess FDA and CE approval trends, clinical trial activity, and post-market safety benchmarking of ophthalmic laser devices.
- REIMBURSEMENT & MARKET ACCESS ANALYSIS – helps you analyze insurance coverage, regional reimbursement variations, and their impact on procedure adoption.
- CAPITAL INVESTMENT & INFRASTRUCTURE TRENDS – helps you evaluate device acquisition costs, payback periods, and investment patterns across hospitals and ambulatory surgical centers.
Ophthalmic Lasers Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 1.72 Billion |
| Market Size by 2035 | USD 2.94 Billion |
| CAGR | CAGR of 5.52% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Type (Photodisruption Lasers, Selective Laser Trabeculoplasty (SLT), Photocoagulation Lasers) • By Product (Diode Lasers, Femtosecond Lasers, Excimer Lasers, Nd: YAG Lasers, SLT Lasers, Other Lasers) • By Application (Glaucoma, Cataract Removal, Refractive Error Corrections, Diabetic Retinopathy, Age-related Macular Degeneration (AMD), Other Applications) • By End User (Outpatient Facilities, Inpatient Facilities) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Rising Demand for Ophthalmic Lasers Market Data, Our Full Report Trend Analysis @ https://www.snsinsider.com/reports/ophthalmic-lasers-market-8319
Other Related Report:
Vision Care Market
Optical Imaging Market
Medical Laser Market
Glaucoma Therapeutics Market
Ophthalmic Diagnostic Devices Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Data Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Publication takes no editorial responsibility for the same.
